Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
---|
01/06/2005 | US20050004376 Process for the production of oxandrolone |
01/06/2005 | US20050004367 Sulfonamide derivatives |
01/06/2005 | US20050004175 Xanthine oxidase inhibitors; hyperuricemia and gout; such as 3-(4-isobutoxy-3-nitrophenyl)-5-(2-methyl-4-pyridyl)-1,2,4-triazole |
01/06/2005 | CA2530581A1 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
01/05/2005 | EP1493744A1 Tropane analogs and methods for inhibition of monoamine transport |
01/05/2005 | EP0996619B1 Tropane analogs and methods for inhibition of monoamine transport |
01/05/2005 | CN1561340A Novel 1, 2, 4-triazole compound |
01/05/2005 | CN1561338A Chroman derivatives as 5-hydroxytryptamine-6 ligands |
01/05/2005 | CN1561337A Stereospecific process for the synthesis of 2-yl chroman derivatives |
01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
01/05/2005 | CN1561209A Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
01/05/2005 | CN1560069A Process for extracting total flavone and total oside of astragalus from astragalus |
01/05/2005 | CN1560048A Extractive of smalt and extracting process thereof |
01/05/2005 | CN1560047A Process for producing soybean isoflavone by waste water of bean products factory |
01/05/2005 | CN1560046A Process for extracting water grind thisvine using alcohole as single organic dissolvent |
01/05/2005 | CN1560005A Process for extracting compound of hemp phenol from hemp seed oil |
01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
01/04/2005 | US6838104 Process for the production of tocotrienols |
01/04/2005 | CA2293834C Substituted naphthopyrans |
12/30/2004 | US20040267013 long-wave absorption maxima in the open form thereof; enables violet to blue tints to be obtained when used in photochromic articles; ophthalmic lenses |
12/30/2004 | US20040266861 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
12/30/2004 | US20040266820 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits |
12/30/2004 | US20040266699 Flavonoid compounds capable of modifying the dynamic and/or physical state of biological membranes and to stimulate the endogenous synthesis of stress proteins in eukaryotic cells, relative synthesis and their use |
12/30/2004 | US20040265742 Photoactive materials |
12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
12/29/2004 | WO2004113320A1 Cannabinoid derivatives, methods of making, and use thereof |
12/29/2004 | WO2004113319A1 Novel chromene compound |
12/29/2004 | WO2004113318A1 Flavanone compound and uses thereof |
12/29/2004 | WO2004113317A1 Novel antimicrobial chroman-4-ones |
12/29/2004 | WO2004112715A2 Methods of making and using theaflavin,theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’ - digallate and mixtures thereof |
12/29/2004 | WO2004046068A3 Non-steroidal farnesoid x receptor modulators and methods for the use thereof |
12/29/2004 | EP1491590A1 Triphenylmethane colorant compounds |
12/29/2004 | EP1491192A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon |
12/29/2004 | EP1490351A1 Production of dihydronepetalactone by hydrogenation of nepetalactone |
12/29/2004 | EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment |
12/29/2004 | EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity |
12/29/2004 | EP0885211B1 Compounds with a sulfamate group |
12/29/2004 | CN1557841A Process for synthetic extraction of polysaccharides, tea-polyphenol, theanine, caffeine from tea |
12/29/2004 | CN1557813A Method for quick microwave hydrolysis of gingko flavone glycoside |
12/29/2004 | CN1182132C Process for preparing natural vitamin E monomester succinate |
12/29/2004 | CN1182131C Process for preparing (full racemic)-alpha-tocopherol |
12/29/2004 | CN1182130C Process for purifying swainsonine in Feng grass |
12/29/2004 | CN1182129C Benzopyran derivatives having leukotriene-antagonistic action |
12/29/2004 | CN1182128C Reagents for the quantitation of active oxygen |
12/29/2004 | CA2526103A1 Cannabinoid derivatives, methods of making, and use thereof |
12/28/2004 | US6835725 Cyanine dye containing heterocylic rings; satisfies light stability, favorable signal/noise rato, damage free application to the substrate material, use in the information layer in a write-once optical data carrier |
12/28/2004 | US6835699 Bicycle lactones, perfumery uses thereof, processes for preparing same and intermediates therefor |
12/28/2004 | US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
12/23/2004 | WO2004111027A1 The isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as the effective constituents |
12/23/2004 | US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis |
12/23/2004 | US20040260076 Isolation, purification and synthesis of procyanidin B2 and uses thereof |
12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
12/23/2004 | US20040259763 Bifunctional agents possessing antioxidant and antiarrhythmic activity |
12/22/2004 | EP1487554A2 Methods for treating deodorizer distillate |
12/22/2004 | EP1274408B1 Use of natural chrysanthone compounds having antiangiogenic activity |
12/22/2004 | CN1556847A Methods for treating deodorizer distillate |
12/22/2004 | CN1556801A Hydrophilipolymer and flavone combined object and medicinal composition containing said combined object |
12/22/2004 | CN1556699A Process for isolating phenolic compounds |
12/22/2004 | CN1556108A Extraction technology of baicalein, medicinal composition and preparation technology of medicine |
12/22/2004 | CN1556101A Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine |
12/22/2004 | CN1181344C Oxidized haematine solution and its preparing process and application |
12/22/2004 | CN1181068C Process for preparing d,I-alpha-tocopherol |
12/22/2004 | CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same |
12/16/2004 | WO2004108077A2 Method of mitigating the adverse effects of il-2 |
12/16/2004 | WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions |
12/16/2004 | US20040254180 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals |
12/16/2004 | US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders |
12/16/2004 | US20040253216 Activated checkpoint therapy and methods of use thereof |
12/16/2004 | US20040252171 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method |
12/16/2004 | CA2526638A1 Method of mitigating the adverse effects of il-2 |
12/15/2004 | EP1486526A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method |
12/15/2004 | EP1485369A1 Blue 3h-naphtho- 2,1-b]-pyran derivatives and use thereof |
12/15/2004 | EP1485368A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity |
12/15/2004 | EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
12/15/2004 | EP1484966A2 Derivatives of isoflavones |
12/15/2004 | EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
12/15/2004 | CN1555361A Butyric acid derivatives |
12/15/2004 | CN1554651A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
12/15/2004 | CN1554625A Total flavone and its extracting method |
12/15/2004 | CN1554624A Extracting process for epimedium total flavone |
12/15/2004 | CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
12/15/2004 | CN1179740C Method for extracting and separating effective part from dogbane |
12/14/2004 | US6831098 Hesperetin pro-forms with enhanced bioavailablility |
12/14/2004 | US6831080 Cinnamide derivatives as KCNQ potassium channel modulators |
12/09/2004 | WO2004106286A1 β-BENZYLOXYASPARTATE DERIVATIVES WITH PHOTOSENSITIVE GROUPS |
12/09/2004 | WO2004105779A2 Green tea and oplyphenol inhibitors of bacterial proteases |
12/09/2004 | WO2004092101A3 Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol |
12/09/2004 | WO2004041804A3 Technical process for isolating homoeriodictyol |
12/09/2004 | US20040249174 Synthesis of cannabinoids |
12/09/2004 | US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists |
12/09/2004 | US20040248850 Compounds for the treatment of HIV infection |
12/09/2004 | US20040245498 Fluorinated oxaanthracenes and their use in liquid-crystal mixtures |
12/08/2004 | EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE |
12/08/2004 | EP1482926A2 Amino-methyl substituted tetracycline compounds |
12/08/2004 | EP1432312A4 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues |
12/08/2004 | EP1216227B1 Preparation of sulfonyl imine compounds |
12/08/2004 | EP0966420B1 2-arylcyclopentane-1,3-diones |
12/08/2004 | CN1553887A A method for isolating phenolic substances or juvabiones from wood comprising knotwood |